Cardiac hypertrophy in mice is characterized by chronic activation of growth-promoting signaling pathways downstream of the insulin receptor, with increased activation of AKT and SGK1 contributing to a hypertrophic response in various conditions (28–30). The gene discussed is SGK1; the disease is cardiac hypertrophy.